TrialClinical pharmacokinetics2023

A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women.

Andrea Lukes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.